Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017611
Filing Date
2025-06-17
Accepted
2025-06-17 20:00:05
Documents
1
Period of Report
2025-06-15

Document Format Files

Seq Description Document Type Size
1 form4-06172025_080601.html 4  
1 form4-06172025_080601.xml 4 6110
  Complete submission text file 0001415889-25-017611.txt   7634
Mailing Address 3 COLUMBUS CIRCLE, SUITE 1710 C/O ARALEZ PHARMACEUTICALS INC. NEW YORK NY 10019
Business Address
KOVEN ANDREW I (Reporting) CIK: 0001258673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 251054804

Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Issuer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)